Ingredient or product comparison
Comparison: GHK-Cu vs Other Anti-Aging Peptides and Compounds
GHK-Cu TGF-β signaling, collagen synthesis, MMP modulation Moderate (multiple small RCTs, histological endpoints) Collagen density (+56.9%), wound healing rate (+42%), wrinkle depth (-31.2%) Strongest evidence for dermal applications; systemic anti-aging claim
This source-based comparison does not add ratings or recommend a winner.
- GHK-Cu
- TGF-β signaling, collagen synthesis, MMP modulation
- Moderate (multiple small RCTs, histological endpoints)
- Collagen density (+56.9%), wound healing rate (+42%), wrinkle depth (-31.2%)
- Strongest evidence for dermal applications; systemic anti-aging claims extrapolated from gene studies
- Matrixyl (Palmitoyl Pentapeptide)
- Collagen I/III synthesis stimulation
- Moderate (industry-funded trials, validated measurement methods)
- Wrinkle volume (-17%), skin roughness (-13%)
- Comparable dermal efficacy to GHK-Cu but without copper-dependent MMP activity
- Argireline (Acetyl Hexapeptide-8)
- SNARE complex inhibition (topical Botox-like)
- Low-Moderate (short-term cosmetic studies)
- Expression line depth (-27% at 4 weeks)
- Temporary effect, no structural tissue remodeling
- Dihexa
- HGF/c-Met pathway activation (neurotrophic)
- Preclinical only
- Cognitive enhancement in rodent models
- No human trial data; mechanism targets CNS, not dermal aging
- NAD+ Precursors (NMN, NR)
- Mitochondrial NAD+ restoration
- Moderate (biomarker studies, no longevity trials)
- NAD+ levels (+40%), VO2 max improvement in small cohorts
- Systemic metabolic target; no direct tissue remodeling like GHK-Cu